Navigation Links
Gerson Lehrman Group and BIO Collaborate to Identify Scientific Expertise for the Seventh Annual BIO Investor Forum
Date:10/24/2008

Conference will be held October 29-31 at the Palace Hotel, San Francisco

NEW YORK, Oct. 24 /PRNewswire/ -- Gerson Lehrman Group, the world's marketplace for expertise, and the Biotechnology Industry Organization (BIO) have set the scientific agenda for the Seventh Annual BIO Investor Forum. Featured therapeutic panels will include some of Gerson Lehrman Group's leading physician consultants along with executives from public and private equity biotechnology companies to discuss:

-- Congestive Heart Failure

-- Cystic Fibrosis

-- Epilepsy

-- Fibromyalgia

-- Lung Cancer

-- Neurodegenerative Diseases

-- Novel Solid Tumor Targets

-- Osteoporosis

-- Pre-ASH Primer

"With the financial markets experiencing an unprecedented level of volatility, investment professionals place a greater premium than ever before on sophisticated expertise to guide their decision-making," said Alexander Saint-Amand, President and Chief Executive Officer of Gerson Lehrman Group. "In the healthcare and biotechnology sectors, highly focused and unbiased education plays a critical role; the BIO Investor Forum brings together the three populations relevant to fully understand how to maneuver in this market: industry executives, sophisticated investors, and the world's top clinical thought leaders."

Through this partnership, BIO tapped Gerson Lehrman Group's network of more than 200,000 experts from around the world to identify clinicians and researchers to serve as panel speakers during the conference. The speakers were specifically identified to focus on some of the most interesting and novel development areas within the biotechnology industry, and represent some of the top clinical minds in their respective fields.

"This year's panel topics focus on disease areas in which we expect innovative new therapies to produce significant clinical advances, representing attractive investment and partnering
'/>"/>

SOURCE Gerson Lehrman Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Gerson Lehrman Group Extends Partnership With BIO to Provide Scientific Expertise for the First Annual BIO National Venture Conference
2. NeoStems Denis Rodgerson, Ph.D. to Lecture on Stem Cells and Regenerative Medicine at University of Nevada Las Vegas Campus
3. Gerson Lehrman Group Announces Partnership With BIO to Provide Scientific Expertise for the BIO CEO & Investor Conference
4. China Pharma Holdings, Inc. Appoints The Ruth Group
5. Simcere Pharmaceutical Group to Announce Third Quarter 2008 Earnings on Thursday, November 6, 2008
6. iMedica Partners With LDM GROUP to Offer ScriptGuide to Physician Practice Customers
7. China Bio Energy Holdings Group Announces Financing and Exercise of Warrants
8. Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials
9. American Red Cross Expands Agreement for Strategic Blood Management(TM) Services from Strategic Healthcare Group LLC
10. Nyer Medical Group, Inc. Reports Revenues of $71.2 Million With Net Loss of $.10 Per Share for Fiscal Year 2008
11. AMERIGROUP Corporation to Discuss Third Quarter Earnings on October 23
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Toronto, Canada (PRWEB) January 14, 2014 ... and its motives and methods in product development and ... of the industry. This mistrust, fueled by concerns about ... further fed by reports of spectacular fines to the ...
(Date:1/14/2014)... 14, 2014 Global Record Systems, ... information technology solutions for patients, physicians, the biopharmaceutical ... announced today the signing of a three-year Research ... Drug Administration (FDA). This initiative is designed ...
(Date:1/14/2014)... Bellingham, Washington, USA, and Cardiff, UK (PRWEB) January 13, ... and photonics technology development leader with more than 20 ... international society for optics and photonics . Hainsey will ... “We are delighted to have Dr. Hainsey join SPIE ...
(Date:1/14/2014)... Rochester, NY (PRWEB) January 14, 2014 During ... is now known as “The Doctor’s Plague.” In this time ... their hands. This led, at times, to the death of ... staff today don’t know that they may be unwittingly transmitting ...
Breaking Biology Technology:The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3
... 20 /PRNewswire-Asia/ -- Sundia MediTech Company, a leading,pharmaceutical ... that,the company was named as a Top 100 ... by China Council for International,Investment Promotion (CCIIP) and ... This ranking covers outsourcing services in IT,pharmaceutical, ...
... ... 7 of the Top 10 pharmaceutical and 3 of the Top 5 medical device companies. ... Charlottesville, VA, San Diego, ... provider of technology and information solutions for the life sciences industry announced today a continuing ...
... , , , SAN ... VIAP ), a biotechnology company focused on the development of ... announced that it received a Staff Determination letter, dated July ... Company has not regained compliance with the minimum $2,500,000 stockholders, ...
Cached Biology Technology:OpenQ Posts a 200% Revenue Growth in the First Half of 2009 2VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ 2VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ 3VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ 4
(Date:4/17/2014)... Ill. A drug under clinical trials to treat ... broad-spectrum drugs that act against various bacteria, fungal infections ... by University of Illinois chemists and collaborators. , Led ... team determined the different ways the drug SQ109 attacks ... to target other pathogens from yeast to malaria ...
(Date:4/17/2014)... new modeling study suggests that fish consumption advisories ... exposure to long-lived contaminants like persistent organic pollutants ... team of researchers including University of Toronto Scarborough ... looks at how different levels of environmental contamination, ... of chemicals in the body influenced exposure in ...
(Date:4/17/2014)... A Kansas State University engineer has developed a ... detects improvised explosive devices. The same technique could ... the Steven M. and Kay L. Theede chair ... nuclear engineering, and his research team have created ... or in car trunks. The distance detection method ...
Breaking Biology News(10 mins):Multitarget TB drug could treat other diseases, evade resistance 2Fish consumption advisories fail to cover all types of contaminants 2Patented research remotely detects nitrogen-rich explosives 2
... Institute of Singapore (GIS) and the Anhui Medical University, China, ... development of psoriasis, a common chronic skin disease. The ... Prof. Liu Jianjun, will be published online on 25 Jan. ... genetic variants in the human genomes of a large cohort ...
... effort to improve rice varieties, a Purdue University researcher was ... domesticated rice by using a process that focuses on one ... studying the gene that decides how many shoots will form ... the gene evolved over time through natural selection and human ...
... January 23, 2009New technology deployed on airplanes is ... Island tropical forests from non-native plants and other ... Service and Carnegie Institution scientists involved in the ... journal Ecosystems and hope it will ...
Cached Biology News:Compromised skin barrier function plays a role in psorasis development 2Gene's past could improve the future of rice 2Scientists use lasers to measure changes to tropical forests 2
... is one of several isoprostanes produced from arachidonic ... renal vasoconstrictor in the rat. 8-iso PGE2 inhibits ... of 0.5 and 5 µM, respectively. When infused ... a concentration of 4 mg/kg/min, 8-iso PGE2 decreases ...
DNA Polymerase I Large (Klenow) Fragment is a DNA polymerase that lacks the 5'Cut Site3' exodeoxyribonuclease activity of intact DNA Polymerase I but it contains the 3'Cut Site5' exodeoxyribonuclease...
... offers both high-speed and high-volume versatility ... rotor options, making it ideal for a ... Versatility , High-speed (up to 15,000 ... high-volume (4 x 250mL) swinging bucket rotors ...
Guanylate Kinase Purified Anti-Mouse, Anti-Rat clone 28, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
Biology Products: